Biophan to detail nanotechnology medical breakthroughs at conference
21 October 2005
Rochester NY, USA. Biophan Technologies, Inc. will be among
nanotechnology industry and research leaders at the upcoming Lux Executive
Summit, a high-profile national conference focused on the business impact of
At the conference, CEO Michael Weiner will detail some of Biophan’s
pioneering nanotechnology-based biomedical applications, including
breakthrough solutions for imaging and drug-delivery, as well as other
multi-billion-dollar healthcare industry segments.
The conference is being organized by Lux Research, a
nanotechnology-oriented research and advisory firm, and will be held in the
Charles Hotel in Cambridge, MA, October 24–25, 2005.
Expected to attend are Global 1000 corporate leaders, researchers,
policymakers and financial leaders who want to understand how nanotechnology
will change products, commerce, and ultimately society.
“A core component of Biophan’s business model and technology portfolio is
based upon the creation of business applications of nanotechnology,” said
Mr. Weiner. “Early on, we recognized the significant potential of
nanotechnology to enable truly revolutionary solutions and improvements in
healthcare and many other industries.”
Biophan has achieved a leadership position in several areas of biomedical
technology. The Company initiated its work in the field by developing
nanotechnology-based solutions to enable the safe and effective Magnetic
Resonance Imaging (MRI) of medical devices and surgical tools. Since then,
the Company has progressed into other areas, such as the drug delivery
marketplace, for which it is developing advanced solutions in its Nanolution
Biophan’s other nanotechnology initiatives include areas such as an
implantable bio-thermal power source designed to power and prolong the life
of implanted medical devices, such as pacemakers, neurostimulators, and
other critical devices. It is co-developing that technology with NASA’s Ames
Center for Nanotechnology.